文献速递神经肿瘤

早期手术对偶发低级别胶质瘤患者总生存的获益:多中心研究

The benefit of early surgery on overall survival in incidental low-grade glioma patients: A multicenter study.
PubMed 文献 · Neuro Oncol · 2022-01-01

该多中心回顾性研究分析了267例偶发弥漫性低级别胶质瘤(iLGG)手术患者的临床、影像和手术数据,总生存率为92.41%,5年和10年估计总生存率分别为98.09%和93.2%。术前肿瘤体积较小(P=.001)和切除程度较高(P=.037)与更长的总生存显著相关,而肿瘤复发受早期手术影响(P=.028)。研究结果强化了支持对iLGG早期手术的证据。

要点

  • 术前肿瘤体积较小与更长的总生存显著相关(P=.006)。
  • 早期手术与肿瘤复发风险降低相关(P=.028)。
  • T2-FLAIR异常全切或超全切在61.62%病例中实现,永久轻度缺损率3.08%。

核心结论

  • 该多中心研究证实了既往关于iLGG手术管理的研究结果,强化了支持对这些病变行早期手术的证据。

研究设计与样本

  • 回顾性分析4个神经外科中心267例因偶发低级别胶质瘤(iLGG)接受手术患者的临床、影像和手术数据。
  • 采用单因素和多因素分析识别总生存(OS)和肿瘤复发(TR)的预测因素。

主要发现

  • 总生存率为92.41%,5年和10年估计OS率分别为98.09%和93.2%。
  • 术前肿瘤体积较低(P=.001)和切除程度较高(P=.037)的患者OS显著更长,与WHO定义的分子分类无关(P=.2)。
  • 最终模型中,OS仅受术前肿瘤体积影响(P=.006),而TR受早期手术影响(P=.028)。
  • 术前肿瘤体积与切除程度呈负相关(rs=-0.44,P<.001)。
  • 术前肿瘤体积中位数为15 cm3,切除程度中位数为95%,61.62%病例实现T2-FLAIR异常全切或超全切。

关键数值与推荐

  • 总生存率92.41%,5年估计OS率98.09%,10年估计OS率93.2%。
  • 术前肿瘤体积中位数15 cm3,切除程度中位数95%。
  • T2-FLAIR异常全切或超全切占61.62%。
  • 再次手术占26.22%,两次手术中位间隔5.5年。
  • 组织学进展为高级别胶质瘤占22.85%(16/70),永久轻度缺损占3.08%。

临床怎么用

  • 对于偶发弥漫性低级别胶质瘤,早期手术可能降低肿瘤复发风险并改善总生存。
  • 术前肿瘤体积较小和切除程度较高的患者总生存更长,支持在安全前提下最大化切除。

局限性

  • 回顾性研究设计可能存在选择偏倚和信息偏倚。
  • 仅纳入4个中心的手术患者,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The role of surgery for incidentally discovered diffuse incidental low-grade gliomas (iLGGs) is debatable and poorly documented in current literature. OBJECTIVE: The aim was to identify factors that influence survival for patients that underwent surgical resection of iLGGs in a large multicenter population. METHODS: Clinical, radiological, and surgical data were retrospectively analyzed in 267 patients operated for iLGG from 4 neurosurgical Centers. Univariate and multivariate analyses were performed to identify predictors of overall survival (OS) and tumor recurrence (TR). RESULTS: The OS rate was 92.41%. The 5- and 10-year estimated OS rates were 98.09% and 93.2%, respectively. OS was significantly longer for patients with a lower preoperative tumor volume (P = .001) and higher extent of resection (EOR) (P = .037), regardless the WHO-defined molecular class (P = .2). In the final model, OS was influenced only by the preoperative tumor volume (P = .006), while TR by early surgery (P = .028). A negative association was found between preoperative tumor volumes and EOR (rs = -0.44, P < .001). The median preoperative tumor volume was 15 cm3. The median EOR was 95%. Total or supratotal resection of T2-FLAIR abnormality was achieved in 61.62% of cases. Second surgery was performed in 26.22%. The median time between surgeries was 5.5 years. Histological evolution to high-grade glioma was detected in 22.85% of cases (16/70). Permanent mild deficits were observed in 3.08% of cases. CONCLUSIONS: This multicenter study confirms the results of previous studies investigating surgical management of iLGGs and thereby strengthens the evidence in favor of early surgery for these lesions.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Ius T, Ng S, Young JS, et al. The benefit of early surgery on overall survival in incidental low-grade glioma patients: A multicenter study. Neuro Oncol. 2022. PMID: 34498069. doi:10.1093/neuonc/noab210

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。